Zhejiang Zhenyuan Share Co Ltd (000705) fair value: what the stock is really worth
As of Nov 17, 2026: fair value (intrinsic value) of Zhejiang Zhenyuan Share Co Ltd stock ¥1.27, price ¥5.94, that is 78.6% below the price, quality 55 out of 100. Rating: strongly overvalued. Calculated from audited financials with 16 of our 26 valuation models and 37 quality factors, updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
Zhejiang Zhenyuan Share Co Ltd
000705 · SHEFar too expensive (fair value 79% below the price) and falling price, but solid company: meets 1 of 3 rules.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 17, 2026.
How to read this chart
60‑month range ¥5.85 – ¥10.99 · fair‑value band ¥0.8900 – ¥1.74 · the ¥5.94 price screens above the ¥1.27 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 17, 2026.
Every Wednesday you see whether Zhejiang Zhenyuan Share Co is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
Zhejiang Zhenyuan Share Co.,Ltd. engages in the manufacture and wholesale of pharmaceutical products in China and internationally.
Show moreShow less
Its products include Chinese herbal medicines and slices, Chinese patent medicines, chemical raw materials, chemical preparations, antibiotics, biochemical drugs, biological products, medical devices, chemical reagents, glass instruments, etc.
The company also provides pharmaceutical logistics, health services, etc.; and engages in the wholesale and retail of pharmaceutical products, pre-packaged food, and bulk food and dairy products. In addition, it sells its pharmaceutical products through online and offline channels.
The company was founded in 1993 and is based in Shaoxing, China.
Stock analysis
Zhejiang Zhenyuan Share Co Ltd (000705) currently trades at ¥5.94, while our model-based Fair Value estimate is ¥1.27, 79% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Economic Profit group reads highest at a median of ¥2.38 per share, and 1 of the 16 models we run sit above the ¥5.94 price.
Bear case: the Earnings-Based group reads lowest at ¥0.9950, and 15 of the 16 models stay below the price. Data coverage for this calculation is low.
Scenario range: ¥0.8900 (bear) to ¥1.74 (bull), the price of ¥5.94 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 55/100 (solid quality), in the Healthcare sector.
Weak Growth: Revenue is shrinking: the last year, the last three and the last five years are all negative.
Zhejiang Zhenyuan Share Co Ltd reported revenue of 2.3B CNY in FY2025 versus 3.6B CNY in FY2021, a compound −10.9%/yr. Reported net income was 22.7M CNY in FY2025, compounding −26.4%/yr from FY2021.
Key figures
Market cap 2.0B CNY (≈ $298M) Micro · P/S ratio 1.16 · EPS (TTM) ¥−0.1400 · Net margin −2.5% · Return on equity −2.4% · Return on assets (EBIT) 2.6% (5-year average) · Operating margin −0.7% · Revenue (TTM) 1.9B CNY.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 14 out of 100 (low confidence).
What moves the price
The share trades about 41% below its 52-week high and 2% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −10% fair-value upside, at −79%, 000705 screens richer than that median.
Fair Value models
All 16 models by family
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Revenue & earnings trend
000705 screens overvalued: fair value 79% below the price. Compare with Eli Lilly and Company →
Compare Zhejiang Zhenyuan Share Co Ltd with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Drug Manufacturers - General · 73 stocks
Valuation Multiplesvs Drug Manufacturers - General median · lower = cheaper
Strength profile in five axes (Snowflake)
VALUE 0: the price sits above our fair-value range.
Context: sector, industry, market
- Is the Health Care sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- Return on assets by industry
- Fair value gap by industry
- PEG screener for stocks with fair value
- Undervalued stocks: Chinese Stocks
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Drug Manufacturers - General stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| Bristol-Myers Squibb Company BMY | $61.35 | $75.91 | +24% | vs 000705 |
| Amgen Inc AMGN | $457.93 | $512.24 | +12% | vs 000705 |
| Gilead Sciences, Inc GILD | $170.26 | $184.89 | +9% | vs 000705 |
| Novartis AG NOVN | CHF 133.28 | CHF 123.08 | −8% | vs 000705 |
| Merck & Co MRK | $143.37 | $129.26 | −10% | vs 000705 |
| AbbVie Inc ABBV | $292.82 | $259.62 | −11% | vs 000705 |
| Pfizer Inc PFE | $28.47 | $24.87 | −13% | vs 000705 |
| Roche Holding RO | CHF 411.00 | CHF 326.56 | −21% | vs 000705 |
| Johnson & Johnson, JNJ | $278.70 | $169.03 | −39% | vs 000705 |
| Eli Lilly and Company LLY | $1,416 | $749.92 | −47% | vs 000705 |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Zhejiang Zhenyuan Share Co Ltd (000705) overvalued or undervalued?
What is the fair value of 000705?
What is the quality score of 000705?
What is the price target for Zhejiang Zhenyuan Share Co Ltd (000705)?
What is the Zhejiang Zhenyuan Share Co Ltd stock forecast for 2026?
What is the revenue of Zhejiang Zhenyuan Share Co Ltd (000705)?
What is the intrinsic value of Zhejiang Zhenyuan Share Co Ltd (000705)?
Is Zhejiang Zhenyuan Share Co Ltd stock overvalued or undervalued in 2026?
Is fair value the same as the market price of 000705?
How much is Zhejiang Zhenyuan Share Co Ltd worth?
What do the bullish and bearish scenarios say about 000705?
How solid is the balance sheet of Zhejiang Zhenyuan Share Co Ltd (000705)?
How far is 000705 from its 52-week high?
Which stocks are comparable to Zhejiang Zhenyuan Share Co Ltd?
Is Zhejiang Zhenyuan Share Co Ltd stock attractive at the current price?
How is the fair value of 000705 calculated?
Is it still worth investing in stocks now?
What is the share price of Zhejiang Zhenyuan Share Co Ltd (000705)?
What should I pay attention to with Zhejiang Zhenyuan Share Co Ltd right now?
Where does the earnings growth of Zhejiang Zhenyuan Share Co Ltd (000705) come from?
Key figures of Zhejiang Zhenyuan Share Co Ltd
How large is the market capitalisation of Zhejiang Zhenyuan Share Co Ltd (000705)?
What is the P/S ratio of Zhejiang Zhenyuan Share Co Ltd (000705)?
What are the earnings per share of Zhejiang Zhenyuan Share Co Ltd (000705)?
What is the net margin of Zhejiang Zhenyuan Share Co Ltd (000705)?
What is the return on equity of Zhejiang Zhenyuan Share Co Ltd (000705)?
What is the EBIT return on assets of Zhejiang Zhenyuan Share Co Ltd (000705)?
What is the operating margin of Zhejiang Zhenyuan Share Co Ltd (000705)?
How fast is revenue growing at Zhejiang Zhenyuan Share Co Ltd (000705)?
How fast are earnings growing at Zhejiang Zhenyuan Share Co Ltd (000705)?
How much free cash flow does Zhejiang Zhenyuan Share Co Ltd (000705) generate?
How much net cash does Zhejiang Zhenyuan Share Co Ltd (000705) hold?
Watch Zhejiang Zhenyuan Share Co Ltd in the live analysis
One click puts Zhejiang Zhenyuan Share Co Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.